Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace

GlycoMimetics defied a hematology biotech pitfall Tuesday, breaking out on strong cancer-drug data as shares of Global Blood Therapeutics and Spark Therapeutics trended in the opposite direction. Source: BioSpace

Rounding out the top five companies behind J&J and Sanofi are AbbVie, Celgene and Merck. Source: BioSpace

As a result, GW has now reacquired full ownership of the development and commercialization rights to the product in the U.S. market. Source: BioSpace

Daiichi Sankyo informed Nektar that it was terminating a collaboration and licensing deal, effective Feb. 4, 2018. Source: BioSpace

The round was led by NEA and included Redmile Group, Partner Fund Management, Rock Springs Capital, LifeSci Venture Partners, Samsara BioCapital, and a large institutional investor. Source: BioSpace

bluebird bio stock has been on an upswing for most of the year, having recently taken a spike after positive news at the ASH Annual Meeting. Source: BioSpace

Pfizer's 2017 wasn't horrible. Just ho-hum. Source: BioSpace

The positive results are spurring the companies to begin seeking approval for the checkpoint inhibitor. Source: BioSpace

This year wasn't big for mergers and acquisitions in biopharma, particularly compared to 2015 and 2016. Source: BioSpace